Above all, PDK1 was a superior prognostic biomarker of ovarian cancer and blocking PDK1 in adjuvant treatment of ovarian cancer is a promising antineoplastic therapy as other types of tumors 17, 23, 40, 41. This evidence concerns the gene PDK1 and ovarian cancer.